Cart
sales@molnova.com
BRD6989
CAS No. 642008-81-9
BRD6989( BRD-6989 | BRD 6989 )
Catalog No. M15440 CAS No. 642008-81-9
A novel potent, selective CDK8 inhibitor with IC50 of 0.5 uM against recombinant Cyclin C/CDK8 complex; displays no activity against several CDKs involved in cell cycle including CDK19 (IC50>30 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 67 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 187 | In Stock |
|
| 50MG | 276 | In Stock |
|
| 100MG | 411 | In Stock |
|
| 200MG | 593 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBRD6989
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel potent, selective CDK8 inhibitor with IC50 of 0.5 uM against recombinant Cyclin C/CDK8 complex; displays no activity against several CDKs involved in cell cycle including CDK19 (IC50>30 uM).
-
DescriptionA novel potent, selective CDK8 inhibitor with IC50 of 0.5 uM against recombinant Cyclin C/CDK8 complex; displays no activity against several CDKs involved in cell cycle including CDK19 (IC50>30 uM); inhibits IFNγ-induced phosphorylation of STAT1 at Ser 727 site in BMDCs, selectively upregulates IL-10 with EC50 of 1 uM.
-
In Vitro——
-
In Vivo——
-
SynonymsBRD-6989 | BRD 6989
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number642008-81-9
-
Formula Weight264.332
-
Molecular FormulaC16H16N4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (94.58 mM)
-
SMILESCC1CCC2=C(C1)C(=C(C(=N2)N)C#N)C3=CN=CC=C3
-
Chemical Name2-amino-6-methyl-4-(pyridin-3-yl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Johannessen L, et al. Nat Chem Biol. 2017 Oct;13(10):1102-1108.
molnova catalog
related products
-
BS-194
BS-194 is a potent, selective, orally bioactive CDK2 inhibitor with IC50 of 2.4 nM, displays 140-fold selectivity over CDK7 (IC50=378 nM); weakly inhibits CDK1, CDK5, CDK7, and CDK9 with IC50 of 30, 30, 250, and 90 nM.
-
8-OH-Dpat
8-OH-Dpat is a serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
-
GW-8510
GW-8510 (GW8510) is a?potent, selective inhibitor of CDK2 with IC50 of 10 nM; displays weak inhibition for CDK1 and CDK4 (IC50=110 and 130 nM, respectively) in vitro biochemical assays.
